Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mitochondrial-targeted plastoquinone therapy prevents early onset muscle weakness that occurs before atrophy during ovarian cancer.
Journal: Molecular metabolism
Published: April 22, 2025
Mitochondrial-targeted plastoquinone therapy ameliorates early onset muscle weakness that precedes ovarian cancer cachexia in mice.
Journal: bioRxiv : the preprint server for biology
Published: November 01, 2024
The mitochondrial-targeted antioxidant SkQ1 prevents skeletal muscle mitochondrial-apoptotic but not necroptotic signalling during ovarian cancer.
Journal: The Journal of physiology
Published: October 31, 2024
Mitohormesis during advanced stages of Duchenne muscular dystrophy reveals a redox-sensitive creatine pathway that can be enhanced by the mitochondrial-targeting peptide SBT-20.
Journal: Redox biology
Published: August 14, 2024
Targeting skeletal muscle health with exercise in people with type 1 diabetes: A protocol for HOMET1D, a prospective observational trial with matched controls.
Journal: PloS one
Published: April 10, 2024
Therapeutic targeting of mitochondria in muscular dystrophies. Editorial focus on: "Mitochondrial creatine sensitivity is lost in the D2.mdx model of Duchenne muscular dystrophy and rescued by the mitochondrial-enhancing compound Olesoxime".
Journal: American journal of physiology. Cell physiology
Published: July 17, 2023
Skeletal and cardiac muscle calcium transport regulation in health and disease.
Journal: Bioscience reports
Published: August 18, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026